Portnoy Mark L. 4
4 · CRYO CELL INTERNATIONAL INC · Filed Aug 26, 2021
Insider Transaction Report
Form 4
Portnoy Mark L.
DirectorCo-CEO10% Owner
Transactions
- Tax Payment
Common Stock
2021-08-24$10.50/sh−25,500$267,750→ 762,014 total - Exercise/Conversion
Common Stock
2021-08-24$2.90/sh+67,816$196,666→ 787,514 total - Exercise/Conversion
Stock Option
2021-08-24$2.90/sh−67,816$196,666→ 0 totalExercise: $2.90From: 2011-08-31Exp: 2021-08-31→ Common Stock (67,816 underlying)
Holdings
- 20,000
Stock Option
Exercise: $7.28From: 2019-12-20Exp: 2029-12-20→ Common Stock (20,000 underlying) - 42,266(indirect: By 401(k))
Common Stock
- 71,529(indirect: By Partnership)
Common Stock
- 59,459
Stock Option
Exercise: $3.14From: 2016-04-15Exp: 2026-04-15→ Common Stock (59,459 underlying) - 20,000
Stock Option
Exercise: $7.92From: 2018-03-08Exp: 2028-03-08→ Common Stock (20,000 underlying) - 22,222
Stock Option
Exercise: $7.53From: 2019-08-30Exp: 2029-08-30→ Common Stock (22,222 underlying)
Footnotes (3)
- [F1]Shares of Common Stock held by Capital Asset Fund #1 Limited Partnership, as to which Mark L. Portnoy may be deemed the beneficial owner as its general partner.
- [F2]Shares of common stock were withheld by the Company as payment for the exercise price of the common stock and associated tax liabilities.
- [F3]Stock options will vest 1/3 on the date of grant, 1/3 on December 1, 2020 and 1/3 on December 1, 2021.